Showing 1971 - 1980 of 2252 results

Showing Results for: “type 1 diabetes”

The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead

People living with diabetes are invited to share their story of better living made possible due to insulin The American Diabetes Association ® (ADA), along with the nation’s leading diabetes organizations, unveiled Let’s Talk Insulin today, a campaign commemorating the 100th anniversary of the discovery of insulin. Throughout the year, the ADA and other organizations in the diabetes community will showcase a century of advancements and innovations in insulin therapy, as well as what’s ahead through educational events, support resources, and advocacy for research funding. “The discovery of

Developing CGM Standards for Virginia Schools

The ADA, represented by Safe at School Director Crystal Woodward, is a long-standing member of the Virginia Diabetes Council (VDC), a volunteer-led diabetes organization that advocates for diabetes prevention, management, and healthier lifestyle choices for Virginians. VDC’s School Working Group, representing a collaboration of ADA, school nurses, diabetes providers, and state agencies, gathered at the Fairfax County Health Department on February 13 to develop standards for the use of continuous glucose monitoring (CGM) in Virginia schools. Robust and strategic stakeholder discussions resulted

Become an Advocate

Sign up today! Become an Diabetes advocate, use your voice to help people with diabetes thrive.

Examine the Facts

Discover the alarming statistics of diabetes in the United States. Find out how it is becoming a nationwide epidemic and explore the cost of diabetes in each state.

Ways to Contribute

Join the ADA in the fight against diabetes. Take action by volunteering, advocating, fundraising, donating, and more. Together, we can end diabetes.

Resources For Lawyers

Access American Diabetes Association’s extensive library of documents that may be useful to attorneys litigating or considering diabetes discrimination cases.

The American Diabetes Association, with Visionary Partners VSP Vision Care and Regeneron, to Address Barriers to Accessing Resources to Manage Ones Eye Health

There are currently more than 37 million American adults living with diabetes. Almost three times that many adults (96 million) are living with prediabetes and 90% are completely unaware. Anyone with diabetes is at risk for diabetes-related eye diseases such as diabetic retinopathy, macular edema, glaucoma, and cataracts. Some groups, however, are at a higher risk of losing their vision or going blind from diabetes, including Black Americans, Hispanics and Latinos, American Indians, and Alaska Natives. While genetic factors likely play a role in these health inequities, so do social, economic

La Asociación Americana de la Diabetes Declaración sobre el recorte de precios de la insulina de Sanofi

“La Asociación Americana de la Diabetes (ADA) es la principal defensora de la asequibilidad de la insulina y trabaja para garantizar que todas las personas con diabetes tengan acceso a la atención que necesitan. La ADA ha liderado el proceso de aprobación de límites de gastos compartidos para la insulina en 22 estados y en el Distrito de Columbia, así como el primer límite federal de copago en Medicare. Nos alienta que los principales fabricantes hayan tomado medidas para que la insulina sea más asequible, pero la lucha no ha terminado. Seguiremos defendiendo los esfuerzos en el Congreso y en

Elizabeth J. Mayer-Davis, PhD, Named American Diabetes Association’s® 2019 Kelly West Award Recipient for Outstanding Achievement in Epidemiology

The American Diabetes Association® (ADA) will present the 2019 Kelly West Award for Outstanding Achievement in Epidemiology to Elizabeth J. Mayer-Davis, PhD. This award recognizes significant contributions to the field of diabetes epidemiology. Dr. Mayer-Davis will be recognized with this honor at the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her Kelly West Award Lecture titled, “ Improving Outcomes—Translating Epidemiology to Clinical Trials ,” on Sunday, June 9. Dr. Mayer-Davis is currently the Cary C. Boshamer